DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-81,413

MERCK SHARP & DOHME CORPORATION
MERCK RESEARCH LABS
DISEASE AREA BIOLOGY, IN VITRO/IN VIVO, & MOLECULAR BIOMARKERS
DEPARTMENTS
KENILWORTH, NEW JERSEY

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974,
as amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have
contributed importantly to the workers'
separation or threat of separation.

The investigation was initiated in response to a petition
filed on March 13, 2012 by a New Jersey state workforce
official on behalf of workers of Merck Sharp & Dohme
Corporation, Merck Research Labs, Disease Area Biology, In
Vitro/In Vivo Biology, and Molecular Biomarkers Departments,
Kenilworth, New Jersey (Merck Research Labs-In Vitro/In Vivo
Biology, and Molecular Biomarkers Departments). The workers'
firm is engaged in activities related to the supply of
pharmaceutical research & development services.
During the course of the investigation, information was
collected from the workers' firm.
Section 222(a)(1) has been met because a significant
number or proportion of the workers in Merck Research Labs-In
Vitro/In Vivo Biology, and Molecular Biomarkers Departments
have become totally or partially separated, or are threatened
to become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has acquired from a foreign country the supply of
services like or directly competitive with those supplied by
the workers which contributed importantly to worker group
separations at Merck Research Labs-In Vitro/In Vivo Biology,
and Molecular Biomarkers Departments.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Merck Research
Labs-In Vitro/In Vivo Biology, and Molecular Biomarkers
Departments, who are engaged in activities related to the
supply of pharmaceutical research and development services,
meet the worker group certification criteria under Section
222(a) of the Act, 19 U.S.C. § 2272(a). In accordance with
Section 223 of the Act, 19 U.S.C. § 2273, I make the following
certification:
"All workers of Merck Sharp & Dohme Corporation, Merck
Research Labs, Disease Area Biology, In Vitro/In Vivo
Biology, and Molecular Biomarkers Departments,
Kenilworth, New Jersey, who became totally or partially
separated from employment on or after March 12, 2011,
through two years from the date of certification, and all
workers in the group threatened with total or partial
separation from employment on the date of certification
through two years from the date of certification, are
eligible to apply for adjustment assistance under Chapter
2 of Title II of the Trade Act of 1974, as amended."
Signed in Washington, D.C., this 18th day of May, 2012

/s/Del Min Amy Chen
______________________________
DEL MIN AMY CHEN
Certifying Officer, Office of
Trade Adjustment Assistance